We started publishing this blog on Sept. 15th 2006, three months ago only.
Beyond our most rosy expectations one of our posts regarding Pfizer has been mentioned yesterday by the Bible of investing blogs, the daily Blog Watch written by James Altucher on TheStreet.com website.
He has been certainly excessively generous in quoting us among first league investing blogs that we discovered reading his column. We are taking this mention as an encouragement to do more and better.
Mick Weinstein, the Editor-in-Chief of SeekingAlpha, deserves also a special mention in this "thank you" post. His website has been our first occasion to reach a broad audience and he has demonstrated a boatload of patience in correcting our posts.
A final "thank you" goes of course to our readers. The only fact that they pick our posts among hundreds of investing news sources and pay their attention to our research for a few minutes is our biggest reward. Their comments and suggestions are always welcome.
Stock picks, comments, links dedicated to long term contrarian and value investors.
EMAIL SUBSCRIPTIONS
About Me
- Vincent Di Carmine
- My daytime job is shipbroker (intermediary in the chartering and sale&purchase of ships) sitting in Europe. During my spare time I'm a value investor managing his own personal portfolio of stocks and mutual funds. I'm a long term value investor in companies which spot market value deeply underrate either their normalized earning power or their equity fair value or in solid dividend plays. It means that I may look for: 1) low Price to Earnings or Price to Book stocks 2) turnaround plays 3) companies with good historical profitability track records tainted by internal temporary solvable problems or cyclical downturn of their industry. 4) Companies with business model or wide moat position supporting the payment of a solid dividend.
Links
Blog Archive
Disclosure
- After posting, my position may change at any moment. I may not change my original post to provide an update on my stock position but, in any case, I will do my utmost to keep readers timely posted about any position change in a new post.
- I may not update my columns in response to events that may transpire subsequent to its original publication date.
- Under no circumstances does the information in my posts represent a recommendation to buy or sell stocks. Such information must be considered only as first step for further research.
No comments:
Post a Comment